Analysis of blood component transfusion and some adverse reactions in myelodysplastic syndroms patients

Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 8

Abstract

Objective To analyze the blood transfusion and adverse reactions in myelodysplastic syndroms (MDS) patients, so as to improve transfusion management in MDS patients. Methods The diagnosis and treatment information of MDS patients with blood transfusion in our hospital from January 2003 to December 2022 were collected, and the component transfusion and adverse reactions were investigated. Results The average infusion volume of red blood cells(RBCs) and platelets were respectively (27.46±43.11 ) and (16.41±24.81 ) in 799 MDS patients, which had no correlation with gender and blood type. The incidence of adverse reactions was 18.27% (146/799), with the most common adverse reactions as delayed serologic transfusion reaction (DSTR) (9.01%, 72/799), followed by non hemolytic fever reaction (4.76%, 38/799) and allergic reaction (4.38%, 35/799). Compared with all patients with transfusion, DSTR was more common in females (P<0.05), with elder age and had more RBCs consumption (all P<0.01). 86.11%(62/72) were Rh system, and 40.28% (29/72) had 2 or more antibodies. The occurrence time of DSTR in some patients was not related to the volume of RBCs trans infusion. Conclusion MDS patients, with more average transfusion volume and higher incidence of adverse reactions especially DSTR, were recommended a strictly limited transfusion schedule and Rh phenotype matching RBC products. The investigation of immune status of MDS patients at different periods is helpful to provide new aspects and therapeutic measures for the pathogenesis of DSTR, and the antibody screening time may adjusted appropriately.

Authors and Affiliations

Wenhao XU, Youshan ZHAO, Chao XIAO, Chunkang CHANG

Keywords

Related Articles

Effects of APOBEC3G on the replications of severe fever with thrombocytopenia syndrome virus

Objective To study the effect of apolipoprotein B mRNA editing enzyme catalytic subunit 3G (APOBEC3G)on virus replication and IL-6 production during severe fever with thrombocytopenia syndrome virus (SFTSV) infection. Me...

Proteomic characterization of platelet-derived extracellular vesicles induced by different activation pathways

Activated platelets secrete bioactive molecules and extracellular vesicles. Platelet-derived extracellular vesicles(PEVs), which are rich in proteins, have become important mediators of intercellular communication and ca...

Research progress on massive transfusion protocol

Massive transfusion protocol (MTP) is a programmatic procedure for massive blood transfusions, which is an important means of patient blood management (PBM) for trauma and massive hemorrhage patients. MTP can be initiate...

Research progress of IgM-enriched human intravenous immunoglobulin products

Comparing with conventional human intravenous immunoglobulin products (hIVIG), IgM-enriched hIVIG have more advantages in the neutralization of pathogens and related toxins, the regulation of complement activity, secreti...

Complement content in plasma under different storage conditions

Objective To investigate the changes in complement content in component blood before blood transfusion. Methods 180 samples from 20 plasma donors were collected at different stages of the preparation process, stored at d...

Download PDF file
  • EP ID EP738611
  • DOI 10.13303/j.cjbt.issn.1004-549x.2023.08.008
  • Views 43
  • Downloads 0

How To Cite

Wenhao XU, Youshan ZHAO, Chao XIAO, Chunkang CHANG (2023). Analysis of blood component transfusion and some adverse reactions in myelodysplastic syndroms patients. Chinese Journal of Blood Transfusion, 36(8), -. https://europub.co.uk/articles/-A-738611